Skip to main content
. 2021 Dec 21;19(12):e3001065. doi: 10.1371/journal.pbio.3001065

Table 1. SARS-CoV-2 sequence summary.

SARS-CoV-2 RNA isolated from apical washes collected from donor 1 infected tissues incubated at 37 or 40°C at 72 h were subjected to amplicon sequencing. Reference (ref) sequences (Wuhan, MN908947.3; England 2, EPI_ISL_407073) were used for consensus alignment and SNP identification. Unique SNPs (not detected in input and >5% base count frequency) and frequency (%base counts) shown. Full SNP analysis presented in S2 Data.

Nucleotide position (Wuhan) Base ref (Wuhan) Base ref (England 2) Base input (England 2) SNP mutation vs. input (Sample ID) SNP frequency (%) Amino acid change (relative to Wuhan)
11379 C C C C>T (37–2) T (91.81) nsp6 (A136V)
15682 T T T T>C (37–2) C (91.69) nsp12 (Y748H)
17725 A A A A>C (37–2) C (91.85) synonymous
18488 T C C no change C (>99.9) nsp14 (I150T)
23605 T G G no change G (>99.9) synonymous
26558 G G G G>A (37–2) A (90.74) synonymous
27631 A A A A>C (37–1) C (73.49) synonymous
27892 A A A A>G (37–1) G (73.99) synonymous
28114 T C T no change T (>99.9) no change
29596 A G G no change G (>99.9) ORF10 (I13M)
6945 T T T T>C (37–3) C (71.77) Nsp3 (I1409T)
8782 C T T no change T (>99.9) synonymous

SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; SNP, single-nucleotide polymorphism.